| CEO Name | Dilip Shanghvi |
| Nationality | India |
| Net Worth Estimation | $21 billion |
Dilip Shanghvi, founder and current CEO of Sun Pharmaceutical Industries Limited, has amassed a net worth of around $21 billion due to the company's status as India's largest pharmaceutical producer and its expansive global presence. His wealth is primarily linked to significant equity ownership and Sun Pharma's market capitalization growth through strategic acquisitions and generics success.
Dilip Shanghvi's estimated net worth of $21,000,000,000 vastly exceeds the pharmaceutical business category's maximum estimated CEO net worth of $500,000,000 by 4,100%. His wealth is over 210 times greater than the industry minimum of $10,000,000.
Business Category: Pharmaceutical
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 500000000 USD
Dilip Shanghvi Performance in Sun Pharmaceutical Industries Limited
Dilip Shanghvi, CEO of Sun Pharmaceutical Industries Limited, is renowned for his strategic leadership and decisive decision-making, driving the company's growth into one of India's largest pharmaceutical firms. His focus on innovation, cost efficiency, and global expansion has significantly enhanced Sun Pharma's market performance and competitive positioning. Under his leadership, the company achieved robust financial results, increased product portfolio diversity, and strong international presence, solidifying its status as a global pharma leader.
Latest News
Sun Pharmaceutical appoints new leadership to drive North America growth
Richard Ascroft was named CEO of Sun Pharma North America in June 2025, succeeding Abhay Gandhi, bringing over 30 years of pharma experience from Takeda and Eli Lilly. Meanwhile, Kirti Ganorkar was promoted to Managing Director of Sun Pharma, succeeding founder Dilip Shanghvi, who will remain Executive Chairman, guiding specialty portfolio strategy.
Source: http://njbiz.com/sun-pharma-names-ascroft-north-america-ceo/